2H08-CAR-T

N/A

Report date: 2023/05/11 15:15:41

Base Information

Drug Name2H08-CAR-T

Drug Alias Name2-H-08-CAR-T2H08-CAR-T

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionAnti-MUC1

TargetsMucin-1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesLg Chemical Ltd

China Registration ClassN/A

Develop Information

Active CompaniesLg Chemical Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A